特里普坦
医学
偏头痛
生活质量(医疗保健)
偏头痛治疗
急性偏头痛
预防性治疗
重症监护医学
儿科
精神科
物理疗法
内科学
替代医学
病理
安慰剂
护理部
作者
Stephen D. Silberstein
出处
期刊:The Lancet
[Elsevier]
日期:2004-01-01
卷期号:363 (9406): 381-391
被引量:345
标识
DOI:10.1016/s0140-6736(04)15440-8
摘要
Migraine is a very common neurobiological headache disorder that is caused by increased excitability of the CNS. It ranks among the world's most disabling medical illnesses. Diagnosis is based on the headache's characteristics and associated symptoms. The economic and societal effect of migraine is substantial: it affects patients' quality of life and impairs work, social activities, and family life. There are many acute and preventive migraine treatments. Acute treatment is either specific (triptans and ergots) or non-specific (analgesics). Disabling migraine should be treated with triptans. Increased headache frequency is an indication for preventive treatment. Preventive treatment decreases migraine frequency and improves quality of life. More treatments are being developed, which provides hope to the many patients whose migraines remain uncontrolled.
科研通智能强力驱动
Strongly Powered by AbleSci AI